- Home
- RES vs MYGN Comparison
RES vs MYGN Comparison
Compare RES & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RES
- MYGN
- Stock Information
- Founded
- RES 1984
- MYGN 1991
- Country
- RES United States
- MYGN United States
- Employees
- RES N/A
- MYGN N/A
- Industry
- RES Oilfield Services/Equipment
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- RES Energy
- MYGN Health Care
- Exchange
- RES Nasdaq
- MYGN Nasdaq
- Market Cap
- RES 1.3B
- MYGN 1.2B
- IPO Year
- RES N/A
- MYGN 1995
- Fundamental
- Price
- RES $5.92
- MYGN $14.18
- Analyst Decision
- RES Sell
- MYGN Hold
- Analyst Count
- RES 3
- MYGN 13
- Target Price
- RES $6.17
- MYGN $22.54
- AVG Volume (30 Days)
- RES 1.4M
- MYGN 1.2M
- Earning Date
- RES 01-30-2025
- MYGN 02-24-2025
- Dividend Yield
- RES 2.71%
- MYGN N/A
- EPS Growth
- RES N/A
- MYGN N/A
- EPS
- RES 0.43
- MYGN N/A
- Revenue
- RES $1,414,999,000.00
- MYGN $823,600,000.00
- Revenue This Year
- RES N/A
- MYGN $13.60
- Revenue Next Year
- RES $8.32
- MYGN $3.25
- P/E Ratio
- RES $13.89
- MYGN N/A
- Revenue Growth
- RES N/A
- MYGN 12.15
- 52 Week Low
- RES $5.54
- MYGN $12.04
- 52 Week High
- RES $8.19
- MYGN $29.30
- Technical
- Relative Strength Index (RSI)
- RES 41.64
- MYGN 55.82
- Support Level
- RES $5.93
- MYGN $14.13
- Resistance Level
- RES $6.38
- MYGN $15.47
- Average True Range (ATR)
- RES 0.23
- MYGN 0.72
- MACD
- RES -0.02
- MYGN 0.27
- Stochastic Oscillator
- RES 19.70
- MYGN 61.38
About RES RPC Inc.
RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. The company's operating segment includes Technical Services and Support Services. It generates maximum revenue from the Technical Services segment. Technical Services segment consists of pressure pumping, downhole tools, coiled tubing, snubbing, nitrogen, well control, wireline, and fishing. Support Services segment consists of drill pipe and related tools, pipe handling, pipe inspection and storage services, and oilfield training and consulting services.
About MYGN Myriad Genetics Inc.
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.